# Orapharma

**Canonical:** https://apis.io/providers/orapharma/  
**Website:** https://www.orapharma.com  
**APIs profiled:** 0

Orapharma is a specialty pharmaceutical company and a division of Bausch Health focused on oral healthcare, developing and commercializing products that help dental professionals improve and maintain periodontal and oral health. Its portfolio includes Arestin (minocycline HCl microspheres for the treatment of periodontitis) and the OSSIX bone-grafting and regeneration products. Headquartered in Bridgewater, New Jersey, Orapharma partners with dental professionals across the continuum of care. Surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network; it publishes no public developer API or portal at this time.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Orapharma Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Pharmaceuticals, Oral Health, Dental, Periodontics, Healthcare, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/orapharma/). Scores are computed from the provider's own public artifacts under a published rubric.
